This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Portfolio Pulse from Avi Kapoor
Top Wall Street analysts initiated coverage on several companies with bullish ratings. Notable initiations include WidePoint Corporation, Syndax Pharmaceuticals, Sempra, Tenax Therapeutics, and CG Oncology, all receiving Buy or Outperform ratings with significant price targets.
October 24, 2024 | 11:40 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS initiated coverage on CG Oncology with a Buy rating and a price target of $60, compared to its closing price of $35.61.
The Buy rating and a price target significantly higher than the current price suggest a strong positive outlook, likely boosting investor confidence and driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
UBS initiated coverage on Syndax Pharmaceuticals with a Buy rating and a price target of $37, compared to its closing price of $18.54.
The Buy rating and a price target that is significantly higher than the current price indicate a strong positive sentiment, likely to attract investor interest and push the stock price higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Jefferies initiated coverage on Sempra with a Buy rating and a price target of $98, higher than its closing price of $85.96.
The Buy rating and a price target above the current price suggest a positive outlook, likely to increase investor interest and drive the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Leerink Partners initiated coverage on Tenax Therapeutics with an Outperform rating and a price target of $16, compared to its closing price of $4.32.
The Outperform rating and a price target significantly higher than the current price indicate a strong positive sentiment, likely to attract investor interest and push the stock price higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
HC Wainwright & Co. initiated coverage on WidePoint Corporation with a Buy rating and a price target of $7, significantly higher than its closing price of $3.68.
The initiation of coverage with a Buy rating and a price target almost double the current price suggests a strong positive outlook, likely boosting investor confidence and driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100